128 related articles for article (PubMed ID: 36006493)
21. ASO Author Reflections: Lymphocyte-to-monocyte ratio as prognostic biomarker in pancreatic ductal adenocarcinoma.
Kubota K; Shimizu A; Soejima Y
Ann Surg Oncol; 2022 Feb; 29(2):1449-1450. PubMed ID: 34618246
[No Abstract] [Full Text] [Related]
22. ASO Author Reflections: PD-L2 Expression in Lung Squamous Cell Carcinoma-One of the Potential Important Prognostic Factors.
Matsubara T; Takada K; Maehara Y
Ann Surg Oncol; 2019 Dec; 26(Suppl 3):676-677. PubMed ID: 31385129
[No Abstract] [Full Text] [Related]
23. ASO Author Reflections: Prognostic Impact of Radiological Splenic Artery Involvement in Pancreatic Ductal Adenocarcinoma of the Body and Tail.
Kitamura K; Esaki M; Sone M; Sugawara S; Hiraoka N; Nara S; Ban D; Takamoto T; Mizui T; Shimada K
Ann Surg Oncol; 2022 Oct; 29(11):7059-7060. PubMed ID: 35648319
[No Abstract] [Full Text] [Related]
24. ASO Author Reflections: ypTNM Stage Grouping in the 8th Edition of the AJCC Cancer Staging Manual Refines the Prognostic Prediction for Patients with Esophageal Squamous Cell Carcinoma Undergoing Neoadjuvant Chemotherapy.
Sudo N; Ichikawa H; Muneoka Y; Hanyu T; Kano Y; Ishikawa T; Hirose Y; Miura K; Shimada Y; Nagahashi M; Sakata J; Kobayashi T; Bamba T; Nakagawa S; Kosugi SI; Wakai T
Ann Surg Oncol; 2021 Feb; 28(2):661-662. PubMed ID: 33001302
[No Abstract] [Full Text] [Related]
25. ASO Author Reflections: Prognostic Value of the Preoperative Tumor Marker Index in Resected Pancreatic Ductal Adenocarcinoma: A Retrospective Single Institutional Study.
Miyata T; Hayashi H; Baba H
Ann Surg Oncol; 2020 Dec; 27(Suppl 3):903-904. PubMed ID: 32840745
[No Abstract] [Full Text] [Related]
26. ASO Author Reflections: Prognostic Index after Neoadjuvant Chemotherapy (PINC) in Pancreatic Ductal Adenocarcinoma as Novel Tumor Regression Grading System.
Redegalli M; Schiavo Lena M
Ann Surg Oncol; 2022 Jun; 29(6):3503. PubMed ID: 35187623
[No Abstract] [Full Text] [Related]
27. ASO Author Reflections: Which of Smoking Duration or Smoking Intensity Contributes to Poor Prognosis After Resection of Non-small Cell Lung Cancer?
Takamori S; Okamoto T; Mori M
Ann Surg Oncol; 2020 Dec; 27(Suppl 3):834-835. PubMed ID: 32642994
[No Abstract] [Full Text] [Related]
28. Extrapulmonary small cell carcinoma: imaging features with radiologic-pathologic correlation.
Berniker AV; Abdulrahman AA; Teytelboym OM; Galindo LM; Mackey JE
Radiographics; 2015; 35(1):152-63. PubMed ID: 25590395
[TBL] [Abstract][Full Text] [Related]
29. ASO Author Reflections: R Status Is a Relevant Prognostic Factor for Recurrence and Survival After Pancreatic Head Resection for Ductal Adenocarcinoma.
Crippa S; Giannone F; Lena MS; Falconi M
Ann Surg Oncol; 2021 Aug; 28(8):4613-4614. PubMed ID: 33586067
[No Abstract] [Full Text] [Related]
30. ASO Author Reflections: Prognostic Stratification and the Value of Adjuvant Therapy in Thoracic Esophageal Squamous Cell Carcinoma Patients After Esophagectomy.
Deng W; Chen J; Xiao Z
Ann Surg Oncol; 2019 Dec; 26(Suppl 3):802-803. PubMed ID: 31654164
[No Abstract] [Full Text] [Related]
31. Extrapulmonary small cell carcinoma: multimodality treatment results.
Sengoz M; Abacioglu U; Salepci T; Eren F; Yumuk F; Turhal S
Tumori; 2003; 89(3):274-7. PubMed ID: 12908782
[TBL] [Abstract][Full Text] [Related]
32. ASO Author Reflections: Socioeconomic Disparities in Use of Surgery for Gastrointestinal Cancers Are Large and Impactful in Poor-Prognosis Cancers.
Swords DS; Scaife CL
Ann Surg Oncol; 2020 Feb; 27(2):342-343. PubMed ID: 31686347
[No Abstract] [Full Text] [Related]
33. ASO Author Reflections: Parathyroid Carcinoma-Setting the Stage for Prognosis.
Lo WM; Patel DT
Ann Surg Oncol; 2018 Dec; 25(Suppl 3):864-865. PubMed ID: 30306369
[No Abstract] [Full Text] [Related]
34. ASO Author Reflections: Does Anatomic Resection Improve Prognosis for Hepatocellular Carcinoma? Assessment from Recurrence Treatment.
Minagawa M; Mise Y; Saiura A
Ann Surg Oncol; 2022 Feb; 29(2):922-923. PubMed ID: 34518940
[No Abstract] [Full Text] [Related]
35. ASO Author Reflections: A New Prognostic Factor for Pancreatic Cancer.
Yoshiya S; Itoh S; Yoshizumi T; Mori M
Ann Surg Oncol; 2021 Jun; 28(6):3208. PubMed ID: 33230752
[No Abstract] [Full Text] [Related]
36. ASO Author Reflections: What are the Survivorship and Prognostic Factors of Patients with Metastatic Solitary Fibrous Tumors?
Outani H; Ueda T
Ann Surg Oncol; 2021 Jul; 28(7):3902-3903. PubMed ID: 33165718
[No Abstract] [Full Text] [Related]
37. ASO Author Reflections: Evaluating NPTXR as a Prognostic Biomarker and Therapeutic Target in Esophageal Squamous Cell Carcinoma.
Shinozuka T; Kanda M; Kodera Y
Ann Surg Oncol; 2024 May; ():. PubMed ID: 38748292
[No Abstract] [Full Text] [Related]
38. ASO Author Reflections: Prognostic Value of Tumor Border Configuration in Colon Cancer.
Qwaider YZ; Berger DL
Ann Surg Oncol; 2021 Jun; 28(6):3415. PubMed ID: 33150551
[No Abstract] [Full Text] [Related]
39. ASO Author Reflections: Clinical Significance of Combined Plasma Fibrinogen Level and Neutrophil-to-Lymphocyte Ratio in Non-small Cell Lung Cancer.
Iwasaki M; Ishihara S; Inoue M
Ann Surg Oncol; 2022 Sep; 29(9):5708-5709. PubMed ID: 35614370
[No Abstract] [Full Text] [Related]
40. ASO Author Reflections: Prognostic Factors for Surgically Resected Intraductal Papillary Neoplasm of Bile Duct.
Uemura S; Higuchi R; Yazawa T; Izumo W; Matsunaga Y; Shiihara M; Ota T; Furukawa T; Yamamoto M
Ann Surg Oncol; 2020 Dec; 27(Suppl 3):842-843. PubMed ID: 32681476
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
